Why Must Clinicians Exercise Caution When Using Aesthetic Laser Systems Or Chemical Peels On Patients With Melasma Or Pih, Particularly In Darker Skin Phototypes? Learn Safe Treatment Strategies For Pigment-Prone Skin.

Clinicians must treat melasma and PIH-prone skin as highly reactive, not simply as excess pigment to be removed. Lasers and chemical peels deliberately create thermal or chemical injury, which can initiate inflammation and stimulate melanocytes. In darker Fitzpatrick phototypes, particularly IV–VI, epidermal melanin also absorbs more treatment energy, increasing the risk of thermal injury, rebound hyperpigmentation, prolonged erythema, and dyschromia.

The central risk is that treatment intended to reduce pigment can create enough inflammation to produce more pigment. Safe treatment therefore depends on accurate assessment, conservative energy or peel parameters, strict photoprotection, test spots, and gradual response-based treatment.

Why Melasma and PIH Require Extra Caution

Inflammation Can Amplify Melanocyte Activity

Melasma and PIH are strongly influenced by inflammation. Thermal laser injury or chemical irritation can activate inflammatory pathways that increase melanocyte activity and melanogenesis.

This creates a difficult treatment cycle: the clinician reduces visible pigment while simultaneously introducing a stimulus that may cause new or darker pigmentation.

Darker Skin Contains More Competing Chromophore

In darker skin phototypes, epidermal melanin competes with the intended target for laser energy absorption. More energy may therefore be deposited superficially, even when the treatment is aimed at a deeper structure.

The result can be excessive epidermal heating, prolonged inflammation, and a higher probability of PIH compared with lighter skin.

Melasma May Exist at Different Depths

Melasma can be predominantly epidermal, dermal, or mixed. The apparent color and clinical presentation do not always establish the depth of pigment with certainty.

Applying an aggressive treatment without considering pigment depth can produce unnecessary thermal or chemical trauma while failing to address the underlying pattern.

How Laser Treatments Can Worsen Pigmentation

Energy Must Be Matched to Skin Response

Advanced systems such as Pico, Nd:YAG, and fractional lasers allow precise control of wavelength, fluence, pulse duration, density, and passes. These controls should be used to customize treatment rather than to pursue the highest immediately tolerated setting.

A conservative first session, followed by adjustment based on erythema, recovery, and pigment response, is generally more defensible than an aggressive single treatment.

Longer Wavelengths May Reduce Epidermal Absorption

For appropriate indications, longer wavelengths such as 1064 nm Nd:YAG can reduce the proportion of energy absorbed by superficial melanin and deliver energy more deeply. This does not eliminate risk; fluence, pulse duration, spot size, cooling, and treatment interval remain important.

Longer pulse durations and lower initial fluence may help distribute energy more safely, with gradual modification across subsequent sessions when the skin response is acceptable.

Fractional Treatment Still Requires Restraint

Fractional devices reduce the treated surface area, but they still create controlled injury. In PIH-prone skin, lower treatment density, fewer passes, and adequate intervals between sessions can reduce cumulative inflammatory stress.

Gentle non-ablative or carefully selected fractional approaches are generally less disruptive than aggressive ablative resurfacing. When resurfacing is appropriate, the clinician must still balance the desired endpoint against the patient's pigmentary risk.

Cooling and Test Spots Matter

Adequate cooling can limit thermal injury and help control inflammation. Test spots are particularly valuable when the patient's response is uncertain, the treatment area is cosmetically prominent, or the planned parameters are near the upper end of the device's range.

A test spot does not guarantee safety, but it provides evidence that is more useful than relying solely on a generalized Fitzpatrick classification.

Why Chemical Peels Can Also Trigger PIH

Chemical Injury Is Still Inflammatory Injury

A peel removes or disrupts portions of the epidermis through chemical action. The depth, concentration, formulation, application time, and number of passes all influence the degree of inflammation and barrier disruption.

Even a treatment that appears less technologically complex than a laser can provoke PIH if it produces excessive irritation or prolonged recovery.

Barrier Damage Increases Environmental Sensitivity

After a peel, the skin is more vulnerable to ultraviolet exposure and other irritants. Ultraviolet radiation can reinforce melanocyte activity and undermine the intended pigment reduction.

Sun protection must therefore begin before treatment and continue immediately afterward, with careful avoidance of direct exposure during recovery.

Repeated Aggression Is Not Automatically Better

Melasma often requires a sustained treatment strategy rather than repeated high-intensity procedures. Short treatment intervals or escalating peel strength before the skin has fully recovered can create cumulative inflammation.

The clinician should evaluate whether the pigment is improving, stable, or becoming more active before repeating or intensifying treatment.

Building a Conservative Treatment Protocol

Start With Diagnosis and Risk Assessment

The evaluation should include the patient's Fitzpatrick phototype, history of PIH, current melasma activity, tendency toward prolonged erythema, recent sun exposure, and use of irritating topical products.

Clinicians should also assess pigment distribution and likely depth, identify active inflammation, and set realistic expectations about gradual improvement and recurrence.

Prepare the Skin Before Treatment

Broad-spectrum sunscreen with SPF greater than 30 should be used before treatment and maintained afterward. Management of active irritation and careful selection of topical pigment-control therapy can help establish a more stable baseline.

Any pretreatment regimen should account for tolerance, contraindications, and the specific procedure being planned.

Use the Lowest Effective Treatment Burden

For lasers, this may mean lower fluence, longer pulse duration, reduced density, fewer passes, smaller treatment areas, and adequate cooling. For peels, it may mean a shallower formulation, shorter exposure, fewer applications, or a longer interval between sessions.

The goal is a clinically meaningful response without provoking prolonged inflammation.

Monitor Recovery Before Escalating

The next treatment should be based on the observed response, not on a fixed assumption that every session should be stronger. Persistent erythema, burning, crusting, unexpected darkening, or prolonged sensitivity should prompt reassessment before further treatment.

A multi-session strategy allows the clinician to identify pigmentary complications early and modify the protocol.

Protect the Skin Afterward

Immediate sun protection, gentle non-comedogenic moisturization, and avoidance of unnecessary irritants support barrier recovery. Depigmenting therapy may be reintroduced once the skin has adequately re-epithelialized and no longer shows significant irritation.

The timing and choice of topical agents should be individualized rather than applied automatically to every patient.

Understanding the Trade-offs

More Aggressive Treatment May Produce Faster Visible Change

Higher fluence, greater density, deeper peels, or more passes can increase the short-term treatment effect. They can also increase inflammation, recovery time, and the risk of worsening pigmentation.

In melasma and darker skin, a slower improvement curve is often preferable to a rapid response followed by rebound hyperpigmentation.

Lower Settings May Require More Sessions

Conservative treatment may not produce dramatic immediate clearance. However, staged sessions provide opportunities to assess tolerance and reduce the likelihood that a single excessive treatment will create a difficult-to-reverse pigmentary complication.

Pigment Improvement May Not Be Permanent

Melasma is influenced by ultraviolet exposure and other triggers, so procedural improvement does not necessarily represent a permanent cure. Maintenance photoprotection and appropriate topical management remain important after the procedure.

Localized Treatment Can Create Contrast

Treating only a small periocular or perioral area may produce visible demarcation if surrounding skin remains darker or becomes pigmentary reactive. The treatment field should be planned with the patient's overall complexion and cosmetic result in mind.

Device Selection Does Not Replace Clinical Judgment

A Pico, Nd:YAG, fractional, diode, or other medical-grade system can offer useful controls, but no device is inherently risk-free for melasma or PIH. Proper wavelength selection, parameter adjustment, diagnosis, and follow-up are more important than the device label alone.

Making the Right Choice for Your Goal

The safest plan is the one that controls inflammation while addressing pigment gradually.

If your primary focus is reducing melasma: Confirm the likely pigment depth, prioritize photoprotection and topical management, and use a conservative staged procedure only when the expected benefit justifies the inflammatory risk.
If your primary focus is treating established PIH: Identify and control the original inflammatory trigger before considering a peel or laser, then use test spots and the lowest effective treatment burden.
If your primary focus is treating darker phototypes: Favor individualized parameters, appropriate longer-wavelength options when indicated, adequate cooling, lower fractional density, fewer passes, and longer recovery intervals.
If your primary focus is minimizing complications: Establish a documented baseline, prepare the skin, obtain informed consent about rebound pigmentation, and reassess the response before escalating treatment.

In pigment-prone skin, successful treatment means reducing unwanted pigment without creating the inflammation that generates more of it.

Summary Table:

Risk Factor	Why It Matters	Safe Strategy
Inflammation stimulates melanocytes	Can worsen pigmentation	Use anti-inflammatory protocols, conservative settings
Epidermal melanin competes for laser energy	Increases thermal injury risk in darker skin	Prefer longer wavelengths, lower fluence, proper cooling
Unknown pigment depth	Misguided treatment can cause trauma	Assess with proper diagnosis, perform test spots
Barrier damage after peels	Increases UV sensitivity and PIH risk	Strict photoprotection, gradual peel strength
Overly aggressive treatment	Rebound hyperpigmentation	Start low, escalate slowly, monitor recovery

Are you looking for safe, effective aesthetic devices for treating melasma and PIH in all skin types? BELIS offers advanced laser and peel systems designed with adjustable parameters and cooling features to help you achieve optimal results while minimizing risks. Our professional-grade equipment is trusted by clinics and premium salons worldwide. Contact our experts today to find the perfect solution for your practice — get in touch!